R&D due to start next year if given the green light
Pharmaceutical鈥檚 firm Merck has revealed plans to build a 拢1bn R&D centre in a central London site opposite King鈥檚 Cross station.
Plans for the AHMM-designed scheme have gone out to consultation, with construction expected to start next year if given the go ahead by Camden council.
Merck, known as MSD in Europe, first announced in December 2017 that it was planning to build a new research hub in London.
The new facility will specialise in developing life-saving medicines and 鈥渂reakthrough鈥� research on diseases associated with aging.
The 10-storey building will include a new entrance to the tube network in its lower ground floor, and its upper storeys will feature a 鈥榖iophillic鈥� facade adorned with plants and greenery.
The site, which is currently occupied by a low-rise art deco building on Euston Road called Belgrove House, is within London鈥檚 鈥楰nowledge Quarter鈥� and close to the Francis Crick biomedical research institute.
Site owner Precis Group is also planning to replace Acorn house, a 1960s office block at a nearby site, with a nine-storey mixed-use block providing 33 affordable homes and 500sq m of office space.
No comments yet